StockData
BKHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends November 30Also trades as BKHAR, BKHAU

Black Hawk Acquisition Corp

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026
$4.03−1.98 (-32.95%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Black Hawk Acquisition Corp revenue by segment

No segment breakdown reported

Black Hawk Acquisition does not break out revenue by segment, region or product in the tagged data of its filings for this period type.